EUDA vs. SLNO

Last updated Apr 1, 2026

Compare and contrast key facts about EUDA Health Holdings Limited (EUDA) and Soleno Therapeutics, Inc. (SLNO).

Performance

EUDA vs. SLNO - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in EUDA Health Holdings Limited (EUDA) and Soleno Therapeutics, Inc. (SLNO). The values are adjusted to include any dividend payments, if applicable.

EUDA vs. SLNO - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021
EUDA EUDA Health Holdings Limited	-78.56%	-48.38%	212.94%	-13.21%	-83.10%	1.04%
SLNO Soleno Therapeutics, Inc.	-27.69%	3.00%	11.68%	1,932.83%	-67.80%	-25.72%

Fundamentals

Market Cap EUDA : $368.03M SLNO : $1.82B
EPS EUDA : $0.01 SLNO : $0.39
PE Ratio EUDA : 1.38K SLNO : 85.34
PS Ratio EUDA : 71.32 SLNO : 9.36
Total Revenue (TTM) EUDA : $5.16M SLNO : $190.41M
Gross Profit (TTM) EUDA : $1.16M SLNO : $96.84M
EBITDA (TTM) EUDA : -$1.99M SLNO : $9.41M

Returns By Period

In the year-to-date period, EUDA achieves a -78.56% return, which is significantly lower than SLNO's -27.69% return.

EUDA

• 1D: -9.13%
• 1M: -49.19%
• YTD: -78.56%
• 6M: -71.46%
• 1Y: -86.39%
• 3Y*: -30.88%
• 5Y*: —
• 10Y*: —

SLNO

• 1D: 9.99%
• 1M: -14.31%
• YTD: -27.69%
• 6M: -50.47%
• 1Y: -53.14%
• 3Y*: 150.11%
• 5Y*: 11.25%
• 10Y*: -9.78%

*Multi-year figures are annualized to reflect compound growth (CAGR)

Return for Risk

EUDA vs. SLNO — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

EUDA

EUDA Risk / Return Rank: 10
EUDA Sharpe Ratio Rank: 16
EUDA Sortino Ratio Rank: 13
EUDA Omega Ratio Rank: 13
EUDA Calmar Ratio Rank: 5
EUDA Martin Ratio Rank: 3

SLNO

SLNO Risk / Return Rank: 10
SLNO Sharpe Ratio Rank: 8
SLNO Sortino Ratio Rank: 10
SLNO Omega Ratio Rank: 10
SLNO Calmar Ratio Rank: 12
SLNO Martin Ratio Rank: 10

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

EUDA vs. SLNO - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for EUDA Health Holdings Limited (EUDA) and Soleno Therapeutics, Inc. (SLNO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	EUDA	SLNO	Difference
Sharpe ratio Return per unit of total volatility	-0.59	-0.83	+0.24
Sortino ratio Return per unit of downside risk	-0.87	-1.09	+0.22
Omega ratio Gain probability vs. loss probability	0.89	0.86	+0.03
Calmar ratio Return relative to maximum drawdown	-0.94	-0.81	-0.13
Martin ratio Return relative to average drawdown	-1.80	-1.51	-0.30
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

EUDA vs. SLNO - Sharpe Ratio Comparison

The current EUDA Sharpe Ratio is -0.59, which is comparable to the SLNO Sharpe Ratio of -0.83. The chart below compares the historical Sharpe Ratios of EUDA and SLNO, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Sharpe Ratios by Period

	EUDA	SLNO	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	-0.59	-0.83	+0.24
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	—	0.05	—
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	—	-0.05	—
Sharpe Ratio (All Time) Calculated using the full available price history	-0.42	-0.09	-0.32

Correlation

The correlation between EUDA and SLNO is -0.03. This indicates that the assets' prices tend to move in opposite directions. Negative correlation can be particularly beneficial for diversification and risk management, as one asset may offset the losses of the other during market fluctuations.

Dividends

EUDA vs. SLNO - Dividend Comparison

Neither EUDA nor SLNO has paid dividends to shareholders.

Tickers have no history of dividend payments

Drawdowns

EUDA vs. SLNO - Drawdown Comparison

The maximum EUDA drawdown since its inception was -96.47%, roughly equal to the maximum SLNO drawdown of -99.86%. Use the drawdown chart below to compare losses from any high point for EUDA and SLNO.

Drawdown Indicators

	EUDA	SLNO	Difference
Max Drawdown Largest peak-to-trough decline	-96.47%	-99.86%	+3.39%
Max Drawdown (1Y) Largest decline over 1 year	-91.55%	-66.04%	-25.51%
Max Drawdown (5Y) Largest decline over 5 years	—	-95.49%	—
Max Drawdown (10Y) Largest decline over 10 years	—	-99.13%	—
Current Drawdown Current decline from peak	-95.08%	-94.90%	-0.18%
Average Drawdown Average peak-to-trough decline	-59.86%	-90.57%	+30.71%
Ulcer Index Depth and duration of drawdowns from previous peaks	47.92%	35.50%	+12.42%

Volatility

EUDA vs. SLNO - Volatility Comparison

EUDA Health Holdings Limited (EUDA) has a higher volatility of 58.63% compared to Soleno Therapeutics, Inc. (SLNO) at 17.95%. This indicates that EUDA's price experiences larger fluctuations and is considered to be riskier than SLNO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	EUDA	SLNO	Difference
Volatility (1M) Calculated over the trailing 1-month period	58.63%	17.95%	+40.68%
Volatility (6M) Calculated over the trailing 6-month period	138.21%	50.62%	+87.59%
Volatility (1Y) Calculated over the trailing 1-year period	146.51%	64.08%	+82.43%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	120.50%	243.38%	-122.88%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	120.50%	185.10%	-64.60%

Financials